High‐dose Methotrexate plus temozolomide with or without rituximab in patients with untreated primary central nervous system lymphoma: A retrospective study from China

High‐dose Methotrexate plus temozolomide with or without rituximab in patients with untreated primary central nervous system lymphoma: A retrospective study from China

Abstract The purpose of this retrospective study was to compare the efficacy and toxicity of high‐dose methotrexate plus temozolomide (MT regimen) and rituximab plus MT (RMT regimen) in patients with untreated primary central nervous system lymphoma (PCNSL). A total of 62 patients with untreated PCN...

Full description

Bibliographic Details
Main Authors:	Cui Chen, Peng Sun, Juan Cui, Shumei Yan, Hao Chen, Yi Xia, Xiwen Bi, Panpan Liu, Yu Wang, Hang Yang, Man Nie, Xue‐Wen Zhang, Wenqi Jiang, Zhi‐Ming Li
Format:	Article
Language:	English
Published:	Wiley 2019-04-01
Series:	Cancer Medicine
Subjects:	chemotherapy high‐dose methotrexate (HD‐MTX) primary central nervous system lymphoma (PCNSL) rituximab temozolomide (TMZ)
Online Access:	https://doi.org/10.1002/cam4.1906

Similar Items

A Novel Approach for Glioblastoma Treatment by Combining Apoptosis Inducers (TMZ, MTX, and Cytarabine) with E.V.A. (Eltanexor, Venetoclax, and A1210477) Inhibiting XPO1, Bcl-2, and Mcl-1
by: Kai Zhao, et al.
Published: (2024-04-01)

Relapsed isolated CNS lymphoma treated with radiotherapy and intrathecal methotrexate followed by high‐dose intravenous methotrexate, rituximab, and temozolomide: A case report
by: Ikhwan Rinaldi, et al.
Published: (2024-03-01)

Temozolomide Efficacy and Metabolism: The Implicit Relevance of Nanoscale Delivery Systems
by: Daria Petrenko, et al.
Published: (2022-05-01)

Therapeutic role of methotrexate in pediatric Crohn’s disease
by: Zlatko Djurić, et al.
Published: (2018-08-01)

Sequential high‐dose methotrexate and cytarabine administration improves outcomes in real‐world patients with primary central nervous system lymphoma: A report from the Australasian Lymphoma Alliance
by: Maciej Tatarczuch, et al.
Published: (2024-08-01)

The landscape of circRNAs in gliomas temozolomide resistance: Insights into molecular pathways
by: Alireza Mafi, et al.
Published: (2024-12-01)

An acute infection due to hepatitis E in the context of a patient with rituximab and methotrexate therapy
by: Francisco Josué Cordero Pérez, et al.
Published: (2024-03-01)

A gene signature predicting prognosis of patients with lower-grade gliomas receiving temozolomide therapy
by: Yanzhi Wan, et al.
Published: (2023-11-01)

Adherence to low-dose methotrexate in children with juvenile idiopathic arthritis using a sensitive methotrexate assay
by: Julia E. Möhlmann, et al.
Published: (2024-05-01)

COMPARATIVE EFFICACY OF RITUXIMAB AND METHOTREXATE MONOTHERAPY IN STANDARD DOSES IN PATIENTS WITH SEVERE SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS (PRELIMINARY RESULTS)
by: E. I. Alexeeva, et al.
Published: (2012-01-01)

Enhanced treatment of breast cancer brain metastases with oncolytic virus expressing anti-CD47 antibody and temozolomide
by: Jing Wang, et al.
Published: (2024-09-01)

Investigating the Stability of Six Phenolic TMZ Ester Analogues, Incubated in the Presence of Porcine Liver Esterase and Monitored by HPLC
by: Leroy A. Shervington, et al.
Published: (2022-05-01)

Phase I study of chlorogenic acid injection for recurrent high-grade glioma with long-term follow-up
by: Zhuang Kang, et al.
Published: (2023-06-01)

Sphenopalatine Ganglion Stimulation Upregulates Transport of Temozolomide across the Blood-Brain Barrier
by: Thana N. Theofanis, et al.
Published: (2020-09-01)

High expression of LncRNA HOTAIR is a risk factor for temozolomide resistance in glioblastoma via activation of the miR-214/β-catenin/MGMT pathway
by: Tian Lan, et al.
Published: (2024-10-01)

Meta‐analysis of whole‐brain radiotherapy plus temozolomide compared with whole‐brain radiotherapy for the treatment of brain metastases from non‐small‐cell lung cancer
by: Yong Xin, et al.
Published: (2018-04-01)

Isoginkgetin—A Natural Compound to Control U87MG Glioblastoma Cell Growth and Migration Activating Apoptosis and Autophagy
by: Maria Antonietta Oliva, et al.
Published: (2022-11-01)

Preparation of transferrin-targeted temozolomide nano-micelles and their anti-glioma effect
by: Jun Yu, et al.
Published: (2024-09-01)

Application of the Central Nervous System International Prognostic Index (CNS-IPI) score in daily practice: a retrospective analysis apart from the clinical trial at two centers in Brazil
by: Thais Fischer, et al.
Published: (2024-04-01)

Oncolytic Newcastle Disease Virus Co-Delivered with Modified PLGA Nanoparticles Encapsulating Temozolomide against Glioblastoma Cells: Developing an Effective Treatment Strategy
by: Zahraa A. Kadhim, et al.
Published: (2022-09-01)

A Delphi study to determine the epidemiology and clinical management of patients treated with HDMTX who develop methotrexate (MTX) delayed elimination in France, Germany, Italy, and the UK
by: Stefan Bielack, et al.
Published: (2024-01-01)

Can 3D-CRT meet the desired dose distribution to target and OARs in glioblastoma? A tertiary cancer center experience
by: Narendra Kumar, et al.
Published: (2020-09-01)

From Laboratory Studies to Clinical Trials: Temozolomide Use in IDH-Mutant Gliomas
by: Xueyuan Sun, et al.
Published: (2021-05-01)

The Interaction of Temozolomide with Blood Components Suggests the Potential Use of Human Serum Albumin as a Biomimetic Carrier for the Drug
by: Marta Rubio-Camacho, et al.
Published: (2020-07-01)

Clinical feasibility of a label-free SERS assay for therapeutic drug monitoring of methotrexate
by: Elodie Dumont, et al.
Published: (2024-06-01)

TMEM2 induces epithelial-mesenchymal transition and promotes resistance to temozolomide in GBM cells
by: Lun Gao, et al.
Published: (2023-06-01)

Radiomic prediction for durable response to high‐dose methotrexate‐based chemotherapy in primary central nervous system lymphoma
by: Haoyi Li, et al.
Published: (2024-09-01)

Primary diffuse large B-cell lymphoma of the central nervous system identified with CSF biomarkers
by: Valentin Loser, et al.
Published: (2024-07-01)

Comparison of Benefits and Risks Associated with Anti-T-Lymphocyte Globulin (ATLG) Serotherapy in Methotrexate (MTX)- versus Mycophenolate Mofetil (MMF)-Based Hematopoietic Stem Cell Transplantation
by: Alexander Nikoloudis, et al.
Published: (2023-02-01)

Kontrollü Metotreksat Salımı İçin Selüloz Temelli Poliüretan Yapıların Sentezi ve Yapısal Özelliklerinin Karakterizasyonu
by: Fatma Bilge Emre, et al.
Published: (2023-10-01)

Combination therapy for management of pemphigus patients with unexpected therapeutic response to rituximab: A report of five cases
by: Zeinab Aryanian, et al.
Published: (2023-11-01)

Persistent Nasal Skin Lesions in Pemphigus Patients and the Role of Methotrexate in Treatment: A Case Series Study
by: Mohamad Reza Kavyani, et al.
Published: (2025-01-01)

Primary central nervous system lymphoma: A diagnostic challenge in a young immunocompetent patient with limited resources
by: Zekarias Seifu Ayalew, et al.
Published: (2024-10-01)

Smurf1 Suppression Enhances Temozolomide Chemosensitivity in Glioblastoma by Facilitating PTEN Nuclear Translocation
by: Lei Dong, et al.
Published: (2022-10-01)

Tumor microenvironment in primary central nervous system lymphoma (PCNSL)
by: Qiqi Jin, et al.
Published: (2024-12-01)

Expression of B-cell activating factor, a proliferating inducing ligand and its receptors in primary central nervous system lymphoma
by: Tobias Birnbaum, et al.
Published: (2013-03-01)

The role of rituximab in the treatment of ANCA-associated vasculitides (AAV)
by: Thomas Daikeler, et al.
Published: (2015-01-01)

Implication of Lactucopicrin in Autophagy, Cell Cycle Arrest and Oxidative Stress to Inhibit U87Mg Glioblastoma Cell Growth
by: Rossella Rotondo, et al.
Published: (2020-12-01)

Ibrutinib in Refractory or Relapsing Primary Central Nervous System Lymphoma: A Systematic Review
by: Gaurav Nepal, et al.
Published: (2022-01-01)

The nanoprodrug of polytemozolomide combines with MGMT siRNA to enhance the effect of temozolomide in glioma
by: Haoyue Xu, et al.
Published: (2023-12-01)